Viewing Study NCT01755494


Ignite Creation Date: 2025-12-25 @ 1:44 AM
Ignite Modification Date: 2026-03-08 @ 1:05 AM
Study NCT ID: NCT01755494
Status: COMPLETED
Last Update Posted: 2013-12-13
First Post: 2012-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus(T2DM) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 diabetes, Saxagliptin, Metformin,Fixed dose combination tablet, Bioequivalence, pharmacokinetic, … View